INVESTORS

SEC Filing

SEC Filing Details

Document Details

Filing Date
Jan 8, 2021
Document Date
Jan 8, 2021
Form Description
An amendment to a SC 13D filing
Filing Group
Other
Company
Protara Therapeutics, Inc.
Issuer
PROTARA THERAPEUTICS, INC.

IR Contact

Justine O’Malley 
Vice President, Investor Relations and Communications 
Phone: 646-817-2836
Email: Justine.OMalley@protaratx.com

Scroll to Top